Literature DB >> 22664721

Impaired myocardial perfusion reserve in patients with fatty liver disease assessed by quantitative myocardial perfusion magnetic resonance imaging.

Shiro Nakamori1, Katsuya Onishi, Hiroshi Nakajima, Yeonyee Elizabeth Yoon, Motonori Nagata, Tairo Kurita, Tomomi Yamada, Kakuya Kitagawa, Kaoru Dohi, Mashio Nakamura, Hajime Sakuma, Masaaki Ito.   

Abstract

BACKGROUND: The purpose of this study was to determine whether the presence of fatty liver is associated with an alteration in myocardial perfusion reserve (MPR). METHODS AND
RESULTS: A retrospective analysis of 65 asymptomatic subjects who underwent both plain abdominal computed tomography and cardiac magnetic resonance imaging (MRI), and who had normal left ventricular wall motion, no regional myocardial ischemia and no myocardial scar on MRI was performed. Stress and rest myocardial perfusion MRI were analyzed by Patlak plot method to quantify myocardial blood flow (MBF) and MPR in 16 myocardial segments. Fatty liver was detected in 18 (28%) of the 65 subjects. No significant difference was found in rest-MBF between subjects with and without fatty liver (1.2 ± 0.75 vs. 1.1 ± 0.67 ml·min(-1)·g(-1), P=0.59). However, MPR was significantly lower in subjects with fatty liver than the non-fatty liver subjects (2.3 ± 0.74 vs. 3.3 ± 1.4, P<0.001). Subjects with fatty liver had a higher prevalence of MPR <2.5 (78% vs. 38%, P<0.005) and higher triglyceride levels (206 ± 61 vs. 92 ± 37 mg/dl, P<0.001). Multivariate analysis revealed the presence of fatty liver as a significant predictor of reduced MPR with an odds ratio of 8.2 (P<0.01).
CONCLUSIONS: Nonalcoholic fatty liver disease is related to reduced MPR, suggesting impaired coronary microcirculation.

Entities:  

Mesh:

Year:  2012        PMID: 22664721     DOI: 10.1253/circj.cj-11-1487

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  11 in total

Review 1.  Cardiac abnormalities in patients with nonalcoholic fatty liver disease : Insights from auxiliary examinations.

Authors:  Yu Dong; Guangsen Li
Journal:  Herz       Date:  2019-09-19       Impact factor: 1.443

Review 2.  The Role of Non-alcoholic Fatty Liver Disease in Cardiovascular Disease.

Authors:  Sven M Francque
Journal:  Eur Cardiol       Date:  2014-07

3.  Cardiac structure and function are altered in type 2 diabetes and non-alcoholic fatty liver disease and associate with glycemic control.

Authors:  Sophie Cassidy; Kate Hallsworth; Christian Thoma; Guy A MacGowan; Kieren G Hollingsworth; Christopher P Day; Roy Taylor; Djordje G Jakovljevic; Michael I Trenell
Journal:  Cardiovasc Diabetol       Date:  2015-02-13       Impact factor: 9.951

Review 4.  Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease.

Authors:  Stefano Ballestri; Amedeo Lonardo; Stefano Bonapace; Christopher D Byrne; Paola Loria; Giovanni Targher
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

Review 5.  Nonalcoholic fatty liver disease as a multi-systemic disease.

Authors:  Hakan Fotbolcu; Elçin Zorlu
Journal:  World J Gastroenterol       Date:  2016-04-28       Impact factor: 5.742

Review 6.  Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease.

Authors:  Alessandro Mantovani; Stefano Ballestri; Amedeo Lonardo; Giovanni Targher
Journal:  Dig Dis Sci       Date:  2016-01-25       Impact factor: 3.199

7.  Subclinical hepatic fibrosis is associated with coronary microvascular dysfunction by myocardial perfusion reserve index: a retrospective cohort study.

Authors:  Alan C Kwan; Janet Wei; Brian P Lee; Eric Luong; Gerran Salto; Trevor-Trung Nguyen; Patrick G Botting; Yunxian Liu; David Ouyang; Joseph E Ebinger; Debiao Li; Mazen Noureddin; Louise Thomson; Daniel S Berman; C Noel Bairey Merz; Susan Cheng
Journal:  Int J Cardiovasc Imaging       Date:  2022-02-02       Impact factor: 2.316

Review 8.  Hepatic function and the cardiometabolic syndrome.

Authors:  Nicolas Wiernsperger
Journal:  Diabetes Metab Syndr Obes       Date:  2013-10-10       Impact factor: 3.168

9.  NAFLD and cardiovascular disease.

Authors:  Elisabete Martins; Ana Oliveira
Journal:  Porto Biomed J       Date:  2018-07-18

10.  The Relationships between Metabolic Disorders (Hypertension, Dyslipidemia, and Impaired Glucose Tolerance) and Computed Tomography-Based Indices of Hepatic Steatosis or Visceral Fat Accumulation in Middle-Aged Japanese Men.

Authors:  Kazutoshi Fujibayashi; Toshiaki Gunji; Hirohide Yokokawa; Toshio Naito; Noriko Sasabe; Mitsue Okumura; Kimiko Iijima; Katsuhiko Shibuya; Teruhiko Hisaoka; Hiroshi Fukuda
Journal:  PLoS One       Date:  2016-03-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.